UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Response to: Implication of Ivabradine in Patients with Acute Heart Failure and Sinus Tachycardia Following Allogeneic Hematopoietic Cell Transplantation

Internal Medicine, 2022, pp.0482-22

2022

Volltextzugriff (PDF)

AML-181 AML With Extramedullary Relapse After Allogeneic SCT Treated Successfully With Decitabine/Venetoclax: A Case Report

Clinical lymphoma, myeloma and leukemia, 2024-09, Vol.24, p.S297-S297

2024

Volltextzugriff (PDF)

CT-186 Impact of Allogeneic Hematopoietic Cell Transplantation (allo-HCT) in First Complete Remission (CR1) in Addition to FLT3 Inhibition With Quizartinib in Acute Myeloid Leukemia (AML) With FLT3–Internal Tandem Duplication (FLT3-ITD): Results from the QuANTUM-First Trial

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S521-S522

2023

Volltextzugriff (PDF)

What is the optimal reduced‐intensity conditioning regimen for patients with classical Hodgkin lymphoma undergoing allogeneic transplantation? – is there a one to use or avoid

British journal of haematology, 2020-08, Vol.190 (4), p.490-492

Epperla, Narendranath

2020

Volltextzugriff (PDF)

Incidence, etiology, risk factors, and outcomes of pre‐engraftment bloodstream infections after first and second allogeneic hematopoietic cell transplantation

Transplant infectious disease, 2022-06, Vol.24 (3), p.e13842-n/a

2022

Volltextzugriff (PDF)

Impact of muscle mass loss assessed by computed tomography on the outcome of allogeneic stem cell transplantation

Leukemia & lymphoma, 2022-06, Vol.63 (7), p.1694-1700

2022

Volltextzugriff (PDF)

Prévention de la rechute des leucémies aiguës et syndromes myélodysplasiques en post-allogreffe : stratégies prophylactique et préemptive (SFGM-TC)

Bulletin du cancer, 2024-09

2024

Volltextzugriff (PDF)

Defibrotide Prophylaxis of Sinusoidal Obstruction Syndrome in Adults Treated With Inotuzumab Ozogamicin Prior to Hematopoietic Stem Cell Transplantation

Frontiers in oncology, 2022-06, Vol.12, p.933317-933317

2022

Volltextzugriff (PDF)

Psychological and physical side effects during G-CSF mobilization in related donors of allo-HCT

Annals of hematology, 2024-08, Vol.103 (8), p.3199-3206

2024

Volltextzugriff (PDF)

Extended Abstract: Lung Injury after Allogeneic Hematopoietic Cell Transplantation

Clinical lymphoma, myeloma and leukemia, 2018-09, Vol.18, p.S128-S130

2018

Volltextzugriff (PDF)

CT-162: Ageing of Long-term Allogeneic Hematopoietic Cell Recipients Compared to Their Donors

Clinical lymphoma, myeloma and leukemia, 2020-09, Vol.20, p.S214-S215

2020

Volltextzugriff (PDF)

Overlapping features of hepatic complications after hematopoietic cell transplantation in a rare T-cell lymphoma: A clinical challenge

Current research in translational medicine, 2024-06, Vol.72 (2), p.103436, Article 103436

2024

Volltextzugriff (PDF)

Skewing of the T-cell receptor repertoire in patients receiving rituximab after allogeneic hematopoietic cell transplantation: what lies beneath?

Leukemia & lymphoma, 2019-06, Vol.60 (7), p.1685-1692

2019

Volltextzugriff (PDF)

Tolerance and efficacy of total body irradiation and cladribine prior to allogeneic hematopoietic cells transplantation in patients with acute myeloid leukemia and myelodysplastic syndromes — synopsis of clinical study

Acta haematologica polonica, 2021-08, Vol.52 (4), p.242-244

2021

Volltextzugriff (PDF)

Accelerated Phase of MPN: What Is It and What to Do About It

Clinical lymphoma, myeloma and leukemia, 2021-09, Vol.21, p.S127-S129

Odenike, Olatoyosi

2021

Volltextzugriff (PDF)

Stratégies préventives et thérapeutiques de la rechute après allogreffe de cellules souches hématopoïétiques pour les LAM pédiatriques (SFGM-TC)

Bulletin du cancer, 2024-06

2024

Volltextzugriff (PDF)

Prise en charge de la GVH digestive aiguë : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)

Bulletin du cancer, 2021-12, Vol.108 (12), p.S30-S38

2021

Volltextzugriff (PDF)

Non-prise de greffe, dysfonctionnement du greffon et érythroblastopénie : mise à jour des définitions, outils diagnostiques et prise en charge : recommandation de la SFGM-TC

Bulletin du cancer, 2023-02, Vol.110 (2), p.S67-S78

2023

Volltextzugriff (PDF)

Graft-versus-tumor effect of post-transplant cyclophosphamide-based allogeneic hematopoietic cell transplantation

Frontiers in immunology, 2024-06, Vol.15, p.1403936

Nakamae, Hirohisa

2024

Volltextzugriff (PDF)

Outcomes associated with allogeneic hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma in the era of novel agents

Cancer medicine (Malden, MA), 2023-04, Vol.12 (7), p.8228-8237

2023

Volltextzugriff (PDF)

Gemtuzumab Ozogamicin Combined With Intensive Chemotherapy in Patients With Acute Myeloid Leukemia Relapsing After Allogenic Stem Cell Transplantation

Clinical lymphoma, myeloma and leukemia, 2020-12, Vol.20 (12), p.791-796

2020

Volltextzugriff (PDF)

Case report: Cellular therapy for hydroa vacciniforme-like lymphoproliferative disorder in pediatric common variable immunodeficiency with chronic active Epstein-Barr virus infection

Frontiers in immunology, 2022-08, Vol.13

2022

Volltextzugriff (PDF)

Danger Signals and Graft-versus-host Disease: Current Understanding and Future Perspectives

Frontiers in immunology, 2016-11, Vol.7, p.539-539

2016

Volltextzugriff (PDF)

1 – 25 von 89

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(77)
Mit Volltextzugriff
(74)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(64)
Science & Technology
(64)
Allo-Hct
(53)
Humans
(36)
Hematology
(31)
Oncology
(27)
Immunology
(22)
Transplantation
(21)
Allogeneic Hematopoietic Cell Transplantation
(20)
Hematopoietic Stem Cell Transplantation - Adverse Effects
(19)
Gvhd
(12)
Hematopoietic Stem Cell Transplantation
(12)
Stem Cell Transplantation
(12)
Graft Vs Host Disease - Etiology
(11)
Hematopoietic Stem Cells
(11)
Allografts
(9)
Transplantation, Homologous
(9)
Adult
(8)
Retrospective Studies
(8)
Female
(7)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Response to: Implication of Ivabradine in Patients with Acute Heart Failure and Sinus Tachycardia Following Allogeneic Hematopoietic Cell Transplantation

AML-181 AML With Extramedullary Relapse After Allogeneic SCT Treated Successfully With Decitabine/Venetoclax: A Case Report

Incidence, Risk Factors for and Outcomes of Transplant‐Associated Thrombotic Microangiopathy

CT-186 Impact of Allogeneic Hematopoietic Cell Transplantation (allo-HCT) in First Complete Remission (CR1) in Addition to FLT3 Inhibition With Quizartinib in Acute Myeloid Leukemia (AML) With FLT3–Internal Tandem Duplication (FLT3-ITD): Results from the QuANTUM-First Trial

Sequencing of novel agents in relapsed/refractory B‐cell acute lymphoblastic leukemia: Blinatumomab and inotuzumab ozogamicin may have comparable efficacy as first or second novel agent therapy in relapsed/refractory acute lymphoblastic leukemia

What is the optimal reduced‐intensity conditioning regimen for patients with classical Hodgkin lymphoma undergoing allogeneic transplantation? – is there a one to use or avoid

Incidence, etiology, risk factors, and outcomes of pre‐engraftment bloodstream infections after first and second allogeneic hematopoietic cell transplantation

Impact of muscle mass loss assessed by computed tomography on the outcome of allogeneic stem cell transplantation

Prévention de la rechute des leucémies aiguës et syndromes myélodysplasiques en post-allogreffe : stratégies prophylactique et préemptive (SFGM-TC)

Defibrotide Prophylaxis of Sinusoidal Obstruction Syndrome in Adults Treated With Inotuzumab Ozogamicin Prior to Hematopoietic Stem Cell Transplantation

Psychological and physical side effects during G-CSF mobilization in related donors of allo-HCT

Extended Abstract: Lung Injury after Allogeneic Hematopoietic Cell Transplantation

CT-162: Ageing of Long-term Allogeneic Hematopoietic Cell Recipients Compared to Their Donors

Overlapping features of hepatic complications after hematopoietic cell transplantation in a rare T-cell lymphoma: A clinical challenge

Skewing of the T-cell receptor repertoire in patients receiving rituximab after allogeneic hematopoietic cell transplantation: what lies beneath?

Tolerance and efficacy of total body irradiation and cladribine prior to allogeneic hematopoietic cells transplantation in patients with acute myeloid leukemia and myelodysplastic syndromes — synopsis of clinical study

Accelerated Phase of MPN: What Is It and What to Do About It

Stratégies préventives et thérapeutiques de la rechute après allogreffe de cellules souches hématopoïétiques pour les LAM pédiatriques (SFGM-TC)

Prise en charge de la GVH digestive aiguë : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC)

Non-prise de greffe, dysfonctionnement du greffon et érythroblastopénie : mise à jour des définitions, outils diagnostiques et prise en charge : recommandation de la SFGM-TC

Graft-versus-tumor effect of post-transplant cyclophosphamide-based allogeneic hematopoietic cell transplantation

Outcomes associated with allogeneic hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma in the era of novel agents

Gemtuzumab Ozogamicin Combined With Intensive Chemotherapy in Patients With Acute Myeloid Leukemia Relapsing After Allogenic Stem Cell Transplantation

Case report: Cellular therapy for hydroa vacciniforme-like lymphoproliferative disorder in pediatric common variable immunodeficiency with chronic active Epstein-Barr virus infection

Danger Signals and Graft-versus-host Disease: Current Understanding and Future Perspectives

Suchergebnisse filtern